Skip to main content
Press release November 11, 2026

Novavax to Participate in Jefferies London Healthcare Conference

Novavax Inc (NVAX)

GAITHERSBURG, Md., Nov. 11, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that company management will participate in the following upcoming investor conference: Jefferies London Healthcare Conference, London, United Kingdom Fireside chat on Tuesday, November 17, 2026, at 5:00 p.m. GMT A live webcast of the fireside chat will be available on the "Events & Presentations" page of the Company's website at ir.novavax.com. A replay of each webcast will be available for 30 days following the presentation. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M ® adjuvant and protein-based nanoparticles. The Company's corporate growth strategy is designed to deliver value via three key strategic pillars: partnering its technology, capital-efficient research and development (R&D) innovation and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid™, R21/Matrix-M™), Matrix technology and research and development assets. Please visit novavax.com and LinkedIn for more information. Contacts: Investors Naina Zaman 240-410-5353 [email protected] Media Yvonne Sprow 240-720-7804 [email protected] SOURCE Novavax, Inc.
View original release